Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Non-daily contraceptives cause fewer side effects and are more satisfying to women, and certain oral contraceptives can treat acne and seborrhoea, with a combination of chlormadinone acetate and ethinyl estradiol being highly effective and safe.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

DiluCap improves how quickly minoxidil and finasteride dissolve and controls the release of melatonin and naltrexone.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Eclipta alba extract is generally safe with mild liver and kidney changes at high doses.

ALRN-6924 may prevent hair loss caused by chemotherapy.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Eclipta alba extract improved learning, memory, and stress-related ulcers in rats without affecting movement or causing anxiety.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

ApoBDs, once seen as waste, are now viewed as potential tools for disease treatment and tissue repair.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Bicalutamide improves hair density in women safely.

CS12192 effectively treats alopecia areata with better safety than current options.

Computational techniques can improve drug development for treating certain conditions.

KX-826 is safe and effectively increases hair count in men with hair loss.

Aconiti Lateralis Preparata Radix helps mouse stem cells grow and turn into bone cells faster than usual methods.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Some natural compounds can protect fish ear cells from damage by certain antibiotics without affecting the antibiotics' ability to fight infections.

The new delivery method for dutasteride is more effective and has fewer side effects.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Finasteride 5-mg oral disintegrating tablets and standard tablets are bioequivalent in healthy adult male Han Chinese volunteers.

The PCL/PHB blend allows for slower, more controlled curcumin release than individual polymers.